↓ Skip to main content

Aromatase inhibitors: the journey from the state of the art to clinical open questions

Overview of attention for article published in Frontiers in oncology, December 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aromatase inhibitors: the journey from the state of the art to clinical open questions
Published in
Frontiers in oncology, December 2023
DOI 10.3389/fonc.2023.1249160
Pubmed ID
Authors

Daniele Generali, Rossana Berardi, Michele Caruso, Marina Cazzaniga, Ornella Garrone, Ida Minchella, Ida Paris, Carmine Pinto, Sabino De Placido

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 1 7%
Student > Bachelor 1 7%
Student > Master 1 7%
Researcher 1 7%
Professor > Associate Professor 1 7%
Other 0 0%
Unknown 9 64%
Readers by discipline Count As %
Arts and Humanities 1 7%
Agricultural and Biological Sciences 1 7%
Social Sciences 1 7%
Unknown 11 79%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2024.
All research outputs
#16,067,611
of 26,181,776 outputs
Outputs from Frontiers in oncology
#5,071
of 22,924 outputs
Outputs of similar age
#161,974
of 375,452 outputs
Outputs of similar age from Frontiers in oncology
#95
of 769 outputs
Altmetric has tracked 26,181,776 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,924 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 375,452 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 769 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.